Reduction of allergic symptoms in NC/Jic Jcl mice fed a diet containing casein phosphopeptide preparation, CPP-III

Animal Science Journal

Volumn 75, Issue 2, 2004, Pages 147-153

  Otani, Hajime ^a   Wakatsuki, Shidue ^a  

^a SHINSHU UNIVERSITY   (Japan)

Author keywords

Allergic reduction; Casein phosphopeptides; Intestinal IgA; NC Jic Jcl mice; Serum IgE

Indexed keywords

BOVINAE;

EID: 2342519439     PISSN: 13443941     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-0929.2004.00169.x     Document Type: Article

References (26)

1. Britton JR, Kastin AJ. 1991. Biologically active polypeptides in milk. American Journal of Medical Science 301, 124-132.
2. Coste M, Rochet V, Leonil J, Molle D, Bouhallab S, Tome D. 1992. Identification of C-terminal peptides of bovine β-casein that enhance proliferation of rat lymphocytes. Immunology Letters 33, 41-46.
3. Eales L-J. 1997. Immunology for Life Scientists: a Basic Introduction, pp. 172-173. John Wiley & Sons, New York.
4. Finkelman FD, Katona IM, Urban JF, Holmes J, Ohara J, Tung AS, Sample JV, Paul WE. 1988. IL-4 is required to generate and sustain in vivo IgE responses. Journal of Immunology 141, 2335-2341.
5. Hata I, Higashiyama S, Otani H. 1998. Identification of a phosphopeptide in bovine αs1-casein digest as a factor influencing proliferation and immunoglobulin production in lymphocyte cultures. Journal of Dairy Research 65, 569-578.
6. Hirayama M, Toyota K, Yamaguchi G, Hidaka H, Naito H. 1992. HPLC analysis of commercial casein phosphopeptides (CPP). Bioscience, Biotechnology, and Biochemistry 56, 1126-1127.
7. Kaminogawa S. 1996. Food allergy, oral tolerance and immunomodulation - their molecular and cellular mechanisms. Bioscience, Biotechnology, and Biochemistry 60, 1749-1756.
8. Kasai T, Honda T, Kiriyama S. 1992. Caseinphosphopeptides (CPP) in feces of rats fed casein diet. Bioscience, Biotechnology, and Biochemistry 56, 1150-1151.
9. Kasai T, Iwasaki R, Tanaka M, Kiriyama S. 1995. Caseinphosphopeptides (CPP) in feces and contents in digestive tract of rats fed casein and CPP preparation. Bioscience, Biotechnology, and Biochemistry 59, 26-30.
10. Kayser H, Meisel H. 1996. Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Letters 383, 18-20.
11. Kenneth WB, John HE, Frank L, Kiyono H, Michael PE, William JK, Hirano T, Kishimoto T, Jerry RM. 1989. Interleukins and IgA synthesis. Journal of Experimental Medicine 169, 2133-2148.
12. Kitamura H, Oshida T, Otani H, Wakaduki S, Kusuhara S. 2002. Milk immunoglobulin levels in sows given a diet containing a commercially available casein phosphopeptide preparation (CPP-I) during pregnancy. Milchwissenschaft 57, 486-489.
13. Lahov E, Regelson W. 1996. Antibacterial and immunostimulating casein derived substances from milk: casecidin, isracidin peptides. Food and Chemical Toxicology 34, 131-145.
14. Leung DYM. 1997. Atopic dermatitis: immunobiology and treatment with immune modulators. Clinical and Experimental Immunology 107, 25-30.
15. Matsuda H, Watanabe N, Gregory PG, Johann S, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Philip WA, Chisei R. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. International Immunology 9, 461-466.
16. Meisel H, Frister H. 1988. Chemical characterization of a caseinophosphopeptide isolated from in vivo digests of a casein diet. Biological Chemistry Hoppe Seyler 369, 1275-1279.
17. Otani H, Kihara Y, Park M. 2000a. The immunoenhancing property of a dietary casein phosphopeptide preparation in mice. Food and Agricultral Immunology 12, 165-173.
18. Otani H, Kitamura H, Park M, Kihara Y, Oshida T, Kusuhara S, Sawada K. 2000b. Enhancement of intestinal IgA levels in piglets by oral administration of a commercially available casein phosphopeptide preparation. Milchwisssenschaft 55, 429-432.
19. Otani H, Nakano K, Kawahara T. 2003. Stimulatory effect of a dietary casein phosphopeptide preparation on the mucosal IgA response of mice to orally ingested lipopolysaccharide from Salmonella typhimurium. Bioscience, Biotechnology, and Biochemistry 67, 729-735.
20. Otani H, Watanabe T, Tashiro Y. 2001. Effects of bovine betacasein (1-28) and its chemically synthesized partial fragments on proliferative responses and immunoglobulin production in mouse spleen cell cultures. Bioscience, Biotechnology, and Biochemistry 65, 2489-2495.
21. Payette K, Weiss NS. 1977. Salivary IgA levels in atopic children. Annual Allergy 39, 328-331.
22. Powrie F, Coffman RL. 1993. Cytokine regulation of T-cell function: Potential for therapeutic intervention. Immunology Today 14, 270-274.
23. Schlimme E, Meisel H. 1995. Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung 39, 1-20.
24. Suto H, Matsuda H, Mitsuishi K, Hira K, Uchida T, Unno T, Ogawa H, Chisei R. 1999. NC/Nga mice: a mouse model for atopic dermatitis. International Archives of Allergy and Immunology 120, 70-75.
25. Tsudzuki M, Watanabe N, Wada A, Nakane Y, Hiroi J, Matsuda H. 1997. Genetic analysis and IgE hyperproduction in the NC/Nga mouse. Immunogenetics 47, 88-90.
26. van Asperen PP, Gleeson M, Kemp AS, Geraghty SB, Mellis CM, Clancy RL. 1985. The relationship between atopy and salivary IgA deficiency in infancy. Clinical and Experimental Immunology 62, 753-757.